 PALO ALTO, Calif.--BUSINESS WIRE--Guardant Health, Inc. Nasdaq: GH, a leading precision oncology company, announced today it will present new data at the 2022 American Society of Clinical Oncology ASCO Annual Meeting from June 3-7 in Chicago. Among the 19 abstracts are oral presentations highlighting the use of real-world data to identify resistance to early treatment in advanced breast cancer and the use of enhanced biomarker analysis to evaluate progression-free survival data in metasta 